These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 32567402

  • 1. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
    Sarkar P, Avram C, Chaudhuri N.
    Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
    [Abstract] [Full Text] [Related]

  • 2. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
    Torrisi SE, Kahn N, Wälscher J, Sarmand N, Polke M, Lars K, Eichinger M, Heussel CP, Palmucci S, Sambataro FM, Sambataro G, Sambataro D, Vancheri C, Kreuter M.
    BMC Pulm Med; 2019 Nov 12; 19(1):213. PubMed ID: 31718637
    [Abstract] [Full Text] [Related]

  • 3. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease.
    Gibson CD, Kugler MC, Deshwal H, Munger JS, Condos R.
    Lung; 2020 Aug 12; 198(4):597-608. PubMed ID: 32591895
    [Abstract] [Full Text] [Related]

  • 4. Advances with pharmacotherapy for the treatment of interstitial lung disease.
    Comes A, Sgalla G, Perrotta A, Richeldi L.
    Expert Opin Pharmacother; 2022 Mar 12; 23(4):483-495. PubMed ID: 34907821
    [Abstract] [Full Text] [Related]

  • 5. Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.
    Li DY, Liu X, Huang JY, Hang WL, Yu GR, Xu Y.
    Ther Adv Respir Dis; 2024 Mar 12; 18():17534666241232561. PubMed ID: 38414439
    [Abstract] [Full Text] [Related]

  • 6. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S.
    Mod Rheumatol; 2021 Jan 12; 31(1):13-19. PubMed ID: 32964766
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
    Lederer C, Buschulte K, Hellmich B, Heußel CP, Kriegsmann M, Polke M, Kreuter M.
    Inn Med (Heidelb); 2023 Mar 12; 64(3):247-259. PubMed ID: 36786822
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P, Piluso M, De Giacomi F, Della Zoppa M, Cassandro R, Harari S, Luppi F, Pesci A.
    Respiration; 2020 Mar 12; 99(10):838-845. PubMed ID: 33264777
    [Abstract] [Full Text] [Related]

  • 19. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL, Maher TM, Acciai V, Mounir B, Quaresma M, Zouad-Lejour L, Wells CD, De Loureiro L.
    Adv Ther; 2020 Jul 12; 37(7):3292-3298. PubMed ID: 32451950
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.